OOIR: Observatory of International Research

Papers

(The H4-Index of RSC Medicinal Chemistry is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery	145
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents	101
Back cover	80
Back cover	75
Inside front cover	72
Designing halogen-free metal–phenolic imidazolium poly(ionic liquids) with multi-functional antibacterial, anti-inflammatory and cell proliferation properties for infected wounds	69
Contents list	65
Back cover	65
Metabolic labelling of cancer cells with glycodendrimers stimulate immune-mediated cytotoxicity	65
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections	62
ATP-competitive inhibitors for cancer treatment – kinases and the world beyond	60
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibition	58
Research progress of anticancer drugs targeting CDK12	53
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators	52
Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure	45
Cytotoxicity of phosphoramidate, bis-amidate and cycloSal prodrug metabolites against tumour and normal cells	43
In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape	41
N-Arylsulfonamide-based adenosine analogues to target RNA cap N7-methyltransferase nsp14 of SARS-CoV-2	40
Biocompatible glycolipid derived from bhilawanol as an antibiofilm agent and a promising platform for drug delivery	40
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation	40
Emerging opportunities in the rewiring of biology through proximity inducing small molecules	36
Design, synthesis and structure–activity relationship analysis of dibenzodiazepinone derivatives against Osimertinib resistant NSCLC	34
Oxadiargyl analogs as potent inhibitors of Toxoplasma gondii protoporphyrinogen oxidase	34
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer	33
Structure–activity relationship study of PROTACs against hematopoietic prostaglandin D₂ synthase	32

Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy	31
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold	30
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking	29
Covalent cannabinoid receptor ligands – structural insight and selectivity challenges	28
Identification of the first structurally validated covalent ligands of the small GTPase RAB27A	28
Design, synthesis, in vitro and in silico evaluation of indole-based tetrazole derivatives as putative anti-breast cancer agents	28
Unusual Ni⋯Ni interaction in Ni(ii) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs	28